Evidence map›Paper›PMID 37879692›Full record

ArticleBMJ open2023

Text messaging intervention to support patients with chronic pain during prescription opioid tapering: protocol for a double-blind randomised controlled trial.

Ali Gholamrezaei, Michael Reece Magee, Amy Gray McNeilage, Leah Dwyer, Hassan Jafari, Alison Michelle Sim, Manuela L Ferreira, Beth D Darnall, Paul Glare, Claire Elizabeth Ashton-James

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Ali GholamrezaeiPain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-8674-450X
Michael Reece MageePain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
Amy Gray McNeilagePain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
Leah DwyerConsumer Advisory Group, Painaustralia, Deakin, Victoria, Australia.
Hassan JafariDepartment of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Alison Michelle SimPain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
Manuela L FerreiraSydney Musculoskeletal Health, Kolling Institute, The University of Sydney, Saint Leonards, New South Wales, Australia.
Beth D DarnallDepartment of Anaesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.
Paul GlarePain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-6850-7025
Claire Elizabeth Ashton-JamesPain Management Research Institute, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia claire.ashton-james@sydney.edu.au.ORCID 0000-0001-5547-4295
The University of Sydney · AUKing's College London · GBStanford University · US

Funding

Research and Mentoring in Innovative Patient Oriented Pain and Opioid ScienceK24DA053564 · NIDA · STANFORD UNIVERSITY · PI Beth Denise Darnall · 2021 to 2026
$1.0M
NIDA NIH HHS K24 DA053564
6 · The paper itself

Abstract

introductionIncreases in pain and interference with quality of life is a common concern among people with chronic non-cancer pain (CNCP) who are tapering opioid medications. Research indicates that access to social and psychological support for pain self-management may help people to reduce their opioid dose without increasing pain and interference. This study evaluates the efficacy of a text messaging intervention designed to provide people with CNCP with social and psychological support for pain self-management while tapering long-term opioid therapy (LTOT) under the guidance of their prescriber. METHODS AND ANALYSIS: A double-blind randomised controlled trial will be conducted. Patients with CNCP (n=74) who are tapering LTOT will be enrolled from across Australia. Participants will continue with their usual care while tapering LTOT under the supervision of their prescribing physician. They will randomly receive either a psychoeducational video and supportive text messaging (two Short Message Service (SMS) per day) for 12 weeks or the video only. The primary outcome is the pain intensity and interference assessed by the Pain, Enjoyment of Life and General Activity scale. Secondary outcomes include mood, self-efficacy, pain cognitions, opioid dose reduction, withdrawal symptoms, and acceptability, feasibility, and safety of the intervention. Participants will complete questionnaires at baseline and then every 4 weeks for 12 weeks and will be interviewed at week 12. This trial will provide evidence for the efficacy of a text messaging intervention to support patients with CNCP who are tapering LTOT. If proven to be efficacious and safe, this low-cost intervention can be implemented at scale. ETHICS AND DISSEMINATION: The study protocol was reviewed and approved by the Northern Sydney Local Health District (Australia). Study results will be published in peer-reviewed journals and presented at scientific and professional meetings. TRIAL REGISTRATION NUMBER: ACTRN12622001423707.

Indexed as

Chronic PainText MessagingAnalgesics, OpioidAustraliaHumansQuality of LifeRandomized Controlled Trials as TopicAnalgesics, Opioidchronic painclinical trialhealth educationpain management

Identifiers

PMID37879692
PMCPMC10603486
OpenAlexW4387940614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.